Interact to see
Advertisement
Advertisement
JMKCX vs MEDEX
JMKCX vs MEDEX Comparison
Open Charts JMKCX vs MEDEX
JHancock Emerging Markets Debt C
Price$8.03
Change-$0.01 (-0.12%)
VolumeN/A
Net Assets1.16B
MFS Emerging Markets Debt R2
Price$12.58
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets7.55B
JMKCX vs MEDEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
JMKCX vs. MEDEX commentary
Oct 07, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMKCX is a Hold and MEDEX is a Hold.
FUNDAMENTALS
Fundamentals
MEDEX has more cash in the bank: 7.55B vs. JMKCX (1.16B). MEDEX (5.02) and JMKCX (5.00) have matching dividends . JMKCX was incepted earlier than MEDEX: JMKCX (11 years) vs MEDEX (17 years). JMKCX (1.89) is less costly to investors than MEDEX (1.32). MEDEX is a more actively managed with annual turnover of: 58.00 vs. JMKCX (38.00). MEDEX has a lower initial minimum investment than JMKCX: MEDEX (0) vs JMKCX (1000). MEDEX annual gain was more profitable for investors over the last year : 7.28 vs. JMKCX (6.72). JMKCX return over 5 years is better than : 12.43 vs. MEDEX (10.98).
| JMKCX | MEDEX | JMKCX / MEDEX | |
| Total Expense Ratio | 1.88 | 1.31 | 144% |
| Annual Report Gross Expense Ratio | 1.89 | 1.32 | 143% |
| Fund Existence | 11 years | 17 years | - |
| Gain YTD | 8.038 | 8.773 | 92% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.16B | 7.55B | 15% |
| Annual Yield % from dividends | 5.00 | 5.02 | 100% |
| Returns for 1 year | 6.72 | 7.28 | 92% |
| Returns for 3 years | 37.66 | 37.92 | 99% |
| Returns for 5 years | 12.43 | 10.98 | 113% |
| Returns for 10 years | 42.13 | 41.76 | 101% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement